Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hyttel

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Journal of Neural Transmission. General Section|January 1, 1992
The pharmacological effect of citalopram residues in the (S)-(+)-enantiomerJ Hyttel, K P Bøgesø, J Perregaard, et al.
Psychopharmacology|January 1, 1993
The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male miceC Sánchez, J Arnt, J Hyttel, et al.
Psychopharmacology|January 1, 1984
Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopramJ Arnt, K F Overø, J Hyttel, et al.
Polish Journal of Pharmacology and Pharmacy|March 1, 1984
Behavioural correlates to the dopamine D-1 and D-2 antagonistsA V Christensen, J Arnt, J Hyttel, et al.
Pharmacology & Toxicology|March 1, 1988
Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in ratsJ Arnt, K P Bøgesø, J Hyttel, et al.
Journal of Medicinal Chemistry|December 1, 1985
3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptakeK P Bøgesø, A V Christensen, J Hyttel, et al.
Psychopharmacology. Supplementum|January 1, 1985
Receptor-binding profiles of neurolepticsJ Hyttel, J J Larsen, A V Christensen, et al.
Journal of Medicinal Chemistry|March 20, 1992
Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indolesJ Perregaard, J Arnt, K P Bøgesø, et al.
Journal of Medicinal Chemistry|July 1, 1991
Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonistsK P Bøgesø, T Liljefors, J Arnt, et al.
Life Sciences|April 16, 1984
Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsA V Christensen, J Arnt, J Hyttel, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Journal of Neural Transmission. General Section|January 1, 1992
The pharmacological effect of citalopram residues in the (S)-(+)-enantiomerJ Hyttel, K P Bøgesø, J Perregaard, et al.
Psychopharmacology|January 1, 1993
The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male miceC Sánchez, J Arnt, J Hyttel, et al.
Psychopharmacology|January 1, 1984
Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopramJ Arnt, K F Overø, J Hyttel, et al.
Polish Journal of Pharmacology and Pharmacy|March 1, 1984
Behavioural correlates to the dopamine D-1 and D-2 antagonistsA V Christensen, J Arnt, J Hyttel, et al.
Pharmacology & Toxicology|March 1, 1988
Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in ratsJ Arnt, K P Bøgesø, J Hyttel, et al.
Journal of Medicinal Chemistry|December 1, 1985
3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptakeK P Bøgesø, A V Christensen, J Hyttel, et al.
Psychopharmacology. Supplementum|January 1, 1985
Receptor-binding profiles of neurolepticsJ Hyttel, J J Larsen, A V Christensen, et al.
Journal of Medicinal Chemistry|March 20, 1992
Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indolesJ Perregaard, J Arnt, K P Bøgesø, et al.
Journal of Medicinal Chemistry|July 1, 1991
Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonistsK P Bøgesø, T Liljefors, J Arnt, et al.
Life Sciences|April 16, 1984
Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsA V Christensen, J Arnt, J Hyttel, et al.
Pageof 10